Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octagam 5% in Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
NCT03348618Phase 4Unknown
- Sponsor
- IMMUNOe Health and Research Centers
- Start
- Nov 2017
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in pediatric acute-onset neuropsychiatric syndrome (PANS), sponsored by IMMUNOe Health and Research Centers. Status: unknown.
02
Drugs
intravenous immunoglobulin G
03
Conditions
pediatric acute-onset neuropsychiatric syndrome (PANS)
Beyond the preview
Go deeper on NCT03348618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348618.